Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07610499

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

To learn if the Creating Opportunities for Personal Empowerment (COPE) intervention is feasible, acceptable, and helpful (compared to usual care) in women with breast cancer who are receiving first line treatment.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location contact

Eileen D Hacker, MD

CONTACT

[email protected]

713-563-4004

Eileen D Hacker, MD

PRINCIPAL_INVESTIGATOR

About this study

Primary Objectives The primary objective of this study is to assess the feasibility and acceptability of the COPE intervention, a nurse-led cognitive-behavioral skills-building intervention, in women undergoing their first line of treatment for breast cancer.

  • The primary endpoint of feasibility will be evaluated by the percentage of participants in the intervention arm who completes at least five of the seven intervention sessions. If at least 70% of the intervention group participants complete five or more intervention sessions, the COPE intervention will be deemed feasible in women undergoing their first line of treatment for breast cancer.
  • The primary endpoint of acceptability will be evaluated by an investigator-developed instrument, the Acceptability of COPE in Breast Cancer Intervention Survey, The COPE intervention will be evaluated as acceptable if ≥50% of participants report that the intervention increased their ability to cope with their breast cancer diagnosis in their response to Question 1, "The COPE sessions affected my ability to cope with my breast cancer diagnosis in the following way: A) Increased my ability to cope with my breast cancer diagnosis: B) Decreased my ability to cope with my breast cancer diagnosis; or C) No change in my ability to cope with my breast cancer diagnosis."

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Eligibility Criteria

  • Female
  • Age 18 years and older
  • Diagnosed with stage I-III breast cancer
  • Receiving first line treatment for breast cancer
  • Receiving treatment at MD Anderson
  • Able to read, speak, and consent in English
  • Able to understand and be willing to sign a written informed consent document
  • Able to complete the study questionnaires and intervention sessions

Exclusion criteria

  • Diagnosed with multiple tumor types
  • Diagnosed with stage IV breast cancer
  • Unable to provide consent, such as cognitively impaired individuals
  • Has a preexisting psychiatric diagnosis (e.g., bipolar depression)

Treatment and study plan

Standard of Care (SOC)

Other

Given by Questionnaires

Intervention sessions

Other

7 week sessions

Primary outcomes

  1. Patient-Reported Outcomes Measurement Questionnaire

    Time frame: Through study completion; an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Eileen D Hacker, MD

CONTACT

[email protected]

713-563-4004

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2029
First posted
May 28, 2026
Registry last updated
May 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.